Botox 200 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FFBS0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,844
Award facts
- Contract value 100% obligated
- $15,843.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,843.84 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 Unit Vials. The contract, issued on December 18, 2025, with an ultimate completion date of January 12, 2026, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (SPE2DR) established through the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V initiative, a $30.3 billion acquisition strategy designed to provide pharmaceutical products and medical consumables to Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has demonstrated substantial performance capacity within the federal pharmaceutical supply chain, with numerous delivery orders issued by the Defense Logistics Agency's Medical Supply Chain division spanning a broad product portfolio including specialty pharmaceuticals, biologics, vaccines, and medical consumables. The company's prime vendor contract, awarded November 13, 2025, with a $500 million ceiling and completion date of December 31, 2036, positions it as a critical regional pharmaceutical supplier for military healthcare operations. No subcontractors are identified on this award, with all performance undertaken directly by the prime contractor at its Park Ridge, Illinois location.
Quick answers
Who was awarded contract SPE2DR26FFBS0?
SPE2DR26FFBS0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 18, 2025.
How much is contract SPE2DR26FFBS0 worth?
The government has obligated $15,844 on SPE2DR26FFBS0.
Is contract SPE2DR26FFBS0 an order under another contract?
Yes. SPE2DR26FFBS0 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.
Was contract SPE2DR26FFBS0 competed?
The extent of competition for SPE2DR26FFBS0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award